# Core Natural Resources, Inc.: financial statements, quarterly

CNR · NYSE · CIK 1710366 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cnr.md) · [Financials](/companies/cnr/financials.md) · [Filings](/companies/cnr/filings.md) · [Insiders](/companies/cnr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cnr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [541](/filings/0001710366-24-000031.md) | [634 d](/filings/0001710366-26-000007.md) | [547](/filings/0001710366-25-000014.md) | [491](/filings/0001710366-25-000017.md) | [553](/filings/0001710366-25-000030.md) | [574 d](/filings/0001710366-26-000007.md) | [1,017](/filings/0001710366-26-000041.md) | [1,102](/filings/0001710366-26-000054.md) | [1,003](/filings/0001710366-25-000030.md) | [1,042 d](/filings/0001710366-26-000007.md) | [1,084](/filings/0001710366-26-000041.md) | [1,141](/filings/0001710366-26-000054.md) |
| Selling, general and administrative | $m | [37.3](/filings/0001710366-24-000031.md) | [23.7 d](/filings/0001710366-25-000010.md) | [20.6](/filings/0001710366-24-000012.md) | [20.9](/filings/0001710366-24-000018.md) | [36.2](/filings/0001710366-24-000031.md) | [37.6 d](/filings/0001710366-25-000010.md) | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | not reported | not reported | [124](/filings/0001710366-25-000014.md) | [71.9](/filings/0001710366-25-000017.md) | [117](/filings/0001710366-25-000030.md) | [37.9 d](/filings/0001710366-26-000007.md) | [(53.9)](/filings/0001710366-26-000041.md) | [(19.3)](/filings/0001710366-26-000054.md) | [(11.8)](/filings/0001710366-25-000030.md) | [(97.1) d](/filings/0001710366-26-000007.md) | [32.7](/filings/0001710366-26-000041.md) | [156](/filings/0001710366-26-000054.md) |
| Interest expense | $m | [6.6](/filings/0001710366-24-000031.md) | [5.2 d](/filings/0001710366-25-000010.md) | [0.9](/filings/0001710366-25-000014.md) | [0.4](/filings/0001710366-25-000017.md) | [4.7](/filings/0001710366-24-000031.md) | [7.1 d](/filings/0001710366-25-000010.md) | [1.7](/filings/0001710366-25-000014.md) | [3.7](/filings/0001710366-25-000017.md) | [10.6](/filings/0001710366-25-000030.md) | [11.4 d](/filings/0001710366-26-000007.md) | [11.2](/filings/0001710366-26-000041.md) | [11.6](/filings/0001710366-26-000054.md) |
| Income tax | $m | [21.0](/filings/0001710366-24-000031.md) | [21.8 d](/filings/0001710366-26-000007.md) | [16.8](/filings/0001710366-25-000014.md) | [9.0](/filings/0001710366-25-000017.md) | [17.5](/filings/0001710366-25-000030.md) | [0.8 d](/filings/0001710366-26-000007.md) | [(4.2)](/filings/0001710366-26-000041.md) | [7.1](/filings/0001710366-26-000054.md) | [(53.0)](/filings/0001710366-25-000030.md) | [(30.4) d](/filings/0001710366-26-000007.md) | [(0.4)](/filings/0001710366-26-000041.md) | [16.5](/filings/0001710366-26-000054.md) |
| Net income | $m | [101](/filings/0001710366-24-000031.md) | [157 d](/filings/0001710366-26-000007.md) | [102](/filings/0001710366-25-000030.md) | [58.1](/filings/0001710366-25-000030.md) | [95.6](/filings/0001710366-25-000030.md) | [30.8 d](/filings/0001710366-26-000007.md) | [(69.3)](/filings/0001710366-26-000054.md) | [(36.6)](/filings/0001710366-26-000054.md) | [31.6](/filings/0001710366-25-000030.md) | [(79.0) d](/filings/0001710366-26-000007.md) | [21.0](/filings/0001710366-26-000054.md) | [126](/filings/0001710366-26-000054.md) |
| Diluted EPS | $ per share | [3.11](/filings/0001710366-24-000031.md) | not reported | [3.39](/filings/0001710366-25-000014.md) | [1.96](/filings/0001710366-25-000017.md) | [3.22](/filings/0001710366-25-000030.md) | not reported | [(1.38)](/filings/0001710366-26-000041.md) | [(0.70)](/filings/0001710366-26-000054.md) | [0.61](/filings/0001710366-25-000030.md) | not reported | [0.41](/filings/0001710366-26-000041.md) | [2.51](/filings/0001710366-26-000054.md) |
| Basic EPS | $ per share | [3.15](/filings/0001710366-24-000031.md) | not reported | [3.40](/filings/0001710366-25-000014.md) | [1.96](/filings/0001710366-25-000017.md) | [3.23](/filings/0001710366-25-000030.md) | not reported | [(1.38)](/filings/0001710366-26-000041.md) | [(0.70)](/filings/0001710366-26-000054.md) | [0.61](/filings/0001710366-25-000030.md) | not reported | [0.41](/filings/0001710366-26-000041.md) | [2.51](/filings/0001710366-26-000054.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [168](/filings/0001710366-24-000031.md) | [199](/filings/0001710366-25-000010.md) | [173](/filings/0001710366-25-000014.md) | [216](/filings/0001710366-25-000017.md) | [332](/filings/0001710366-25-000030.md) | [408](/filings/0001710366-26-000007.md) | [388](/filings/0001710366-26-000041.md) | [413](/filings/0001710366-26-000054.md) | [445](/filings/0001710366-25-000030.md) | [432](/filings/0001710366-26-000054.md) | [413](/filings/0001710366-26-000041.md) | [473](/filings/0001710366-26-000054.md) |
| Current assets | $m | [579](/filings/0001710366-23-000022.md) | [601](/filings/0001710366-25-000010.md) | [614](/filings/0001710366-24-000012.md) | [621](/filings/0001710366-24-000018.md) | [745](/filings/0001710366-24-000031.md) | [786](/filings/0001710366-26-000007.md) | [1,333](/filings/0001710366-25-000014.md) | [1,272](/filings/0001710366-25-000017.md) | [1,400](/filings/0001710366-25-000030.md) | [1,340](/filings/0001710366-26-000054.md) | [1,271](/filings/0001710366-26-000041.md) | [1,375](/filings/0001710366-26-000054.md) |
| Total assets | $m | [2,660](/filings/0001710366-24-000031.md) | [2,675](/filings/0001710366-26-000007.md) | [2,680](/filings/0001710366-25-000014.md) | [2,710](/filings/0001710366-25-000017.md) | [2,824](/filings/0001710366-25-000030.md) | [2,880](/filings/0001710366-26-000007.md) | [6,252](/filings/0001710366-26-000041.md) | [6,209](/filings/0001710366-26-000054.md) | [6,196](/filings/0001710366-25-000030.md) | [6,130](/filings/0001710366-26-000054.md) | [6,056](/filings/0001710366-26-000041.md) | [6,122](/filings/0001710366-26-000054.md) |
| Current liabilities | $m | [454](/filings/0001710366-23-000022.md) | [444](/filings/0001710366-25-000010.md) | [417](/filings/0001710366-24-000012.md) | [400](/filings/0001710366-24-000018.md) | [540](/filings/0001710366-24-000031.md) | [519](/filings/0001710366-26-000007.md) | [704](/filings/0001710366-25-000014.md) | [714](/filings/0001710366-25-000017.md) | [770](/filings/0001710366-25-000030.md) | [838](/filings/0001710366-26-000054.md) | [747](/filings/0001710366-26-000041.md) | [753](/filings/0001710366-26-000054.md) |
| Total liabilities | $m | [1,351](/filings/0001710366-23-000022.md) | [1,332](/filings/0001710366-25-000010.md) | [1,291](/filings/0001710366-24-000012.md) | [1,272](/filings/0001710366-24-000018.md) | [1,295](/filings/0001710366-24-000031.md) | [1,311](/filings/0001710366-26-000007.md) | [2,356](/filings/0001710366-25-000014.md) | [2,441](/filings/0001710366-25-000017.md) | [2,417](/filings/0001710366-25-000030.md) | [2,452](/filings/0001710366-26-000054.md) | [2,399](/filings/0001710366-26-000041.md) | [2,403](/filings/0001710366-26-000054.md) |
| Long-term debt | $m | [183](/filings/0001710366-23-000022.md) | [182](/filings/0001710366-25-000010.md) | [182](/filings/0001710366-24-000012.md) | [182](/filings/0001710366-24-000018.md) | [79.3](/filings/0001710366-24-000031.md) | [79.5](/filings/0001710366-26-000007.md) | [313](/filings/0001710366-25-000014.md) | [313](/filings/0001710366-25-000017.md) | [313](/filings/0001710366-25-000030.md) | [317](/filings/0001710366-26-000007.md) | not reported | not reported |
| Current portion of debt | $m | [2.0](/filings/0001710366-23-000022.md) | [1.6](/filings/0001710366-25-000010.md) | [1.4](/filings/0001710366-24-000012.md) | [1.2](/filings/0001710366-24-000018.md) | [108](/filings/0001710366-24-000031.md) | [104](/filings/0001710366-26-000007.md) | [28.0](/filings/0001710366-25-000014.md) | [45.6](/filings/0001710366-25-000017.md) | [71.1](/filings/0001710366-25-000030.md) | [77.6](/filings/0001710366-26-000007.md) | not reported | not reported |
| Shareholders' equity | $m | [1,309](/filings/0001710366-24-000031.md) | [1,343](/filings/0001710366-26-000007.md) | [1,389](/filings/0001710366-25-000030.md) | [1,438](/filings/0001710366-25-000030.md) | [1,529](/filings/0001710366-25-000030.md) | [1,568](/filings/0001710366-26-000054.md) | [3,896](/filings/0001710366-26-000054.md) | [3,768](/filings/0001710366-26-000054.md) | [3,779](/filings/0001710366-25-000030.md) | [3,678](/filings/0001710366-26-000054.md) | [3,657](/filings/0001710366-26-000054.md) | [3,719](/filings/0001710366-26-000054.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [163 d](/filings/0001710366-24-000031.md) | [219 d](/filings/0001710366-26-000007.md) | [77.5](/filings/0001710366-25-000014.md) | [116 d](/filings/0001710366-25-000017.md) | [161 d](/filings/0001710366-25-000030.md) | [121 d](/filings/0001710366-26-000007.md) | [(110)](/filings/0001710366-26-000041.md) | [220 d](/filings/0001710366-26-000054.md) | [87.9 d](/filings/0001710366-25-000030.md) | [107 d](/filings/0001710366-26-000007.md) | [119](/filings/0001710366-26-000041.md) | [250 d](/filings/0001710366-26-000054.md) |
| Capital expenditure | $m | [41.7](/filings/0001710366-23-000022.md) | [50.0 d](/filings/0001710366-26-000007.md) | [42.4](/filings/0001710366-25-000014.md) | [55.4 d](/filings/0001710366-25-000017.md) | [39.4 d](/filings/0001710366-25-000030.md) | [40.8 d](/filings/0001710366-26-000007.md) | [64.8](/filings/0001710366-26-000041.md) | [89.2 d](/filings/0001710366-26-000054.md) | [49.3 d](/filings/0001710366-25-000030.md) | [81.3 d](/filings/0001710366-26-000007.md) | [73.1](/filings/0001710366-26-000041.md) | [102 d](/filings/0001710366-26-000054.md) |
| Dividends paid | $m | [0.0 d](/filings/0001710366-24-000031.md) | [0.0 d](/filings/0001710366-26-000007.md) | [0.6](/filings/0001710366-25-000014.md) | [0.5 d](/filings/0001710366-25-000017.md) | [7.4 d](/filings/0001710366-25-000030.md) | [7.4 d](/filings/0001710366-26-000007.md) | [10.7](/filings/0001710366-26-000041.md) | [5.2 d](/filings/0001710366-26-000054.md) | [5.1 d](/filings/0001710366-25-000030.md) | [5.2 d](/filings/0001710366-26-000007.md) | [5.1](/filings/0001710366-26-000041.md) | [5.0 d](/filings/0001710366-26-000054.md) |
| Share repurchases | $m | [137 d](/filings/0001710366-24-000031.md) | [122 d](/filings/0001710366-26-000007.md) | [57.9](/filings/0001710366-25-000014.md) | [13.0 d](/filings/0001710366-25-000017.md) | [0.0 d](/filings/0001710366-25-000030.md) | [0.0 d](/filings/0001710366-26-000007.md) | [101](/filings/0001710366-26-000041.md) | [81.9 d](/filings/0001710366-26-000054.md) | [19.4 d](/filings/0001710366-25-000030.md) | [21.7 d](/filings/0001710366-26-000007.md) | [41.9](/filings/0001710366-26-000041.md) | [63.0 d](/filings/0001710366-26-000054.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [35.8](/filings/0001710366-23-000022.md) | [35.2](/filings/0001710366-24-000012.md) | [34.0](/filings/0001710366-24-000018.md) | [32.4](/filings/0001710366-24-000031.md) | [30.1](/filings/0001710366-25-000014.md) | [29.7](/filings/0001710366-25-000017.md) | [29.7](/filings/0001710366-25-000030.md) | [50.3](/filings/0001710366-26-000041.md) | [52.4](/filings/0001710366-26-000054.md) | [51.6](/filings/0001710366-25-000030.md) | [51.1](/filings/0001710366-26-000041.md) | [50.5](/filings/0001710366-26-000054.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 49,636,257 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001710366-26-000054.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.